Seer, Inc. (California) (SEER)
2.05
+0.01
(+0.49%)
USD |
NASDAQ |
Aug 25, 09:30
Seer Debt to Equity Ratio : 0.0992 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0992 |
| March 31, 2026 | 0.0954 |
| December 31, 2025 | 0.0912 |
| September 30, 2025 | 0.0892 |
| June 30, 2025 | 0.0861 |
| March 31, 2025 | 0.0817 |
| December 31, 2024 | 0.0793 |
| September 30, 2024 | 0.0769 |
| June 30, 2024 | 0.0743 |
| March 31, 2024 | 0.0722 |
| December 31, 2023 | 0.0712 |
| September 30, 2023 | 0.071 |
| June 30, 2023 | 0.0702 |
| March 31, 2023 | 0.069 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0668 |
| September 30, 2022 | 0.0651 |
| June 30, 2022 | 0.0636 |
| March 31, 2022 | 0.0621 |
| December 31, 2021 | 0.0464 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Champions Oncology, Inc. | 1.167 |
| Medpace Holdings, Inc. | 0.3322 |
| Avantor, Inc. | 0.6568 |
| Personalis, Inc. | 0.1616 |
| Adaptive Biotechnologies Corp. | 2.872 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 256.64M |
| Total Liabilities (Quarterly) | 30.96M |
| Shareholders Equity (Quarterly) | 225.68M |
| Current Ratio | 14.74 |
| Net Debt Paydown Yield | 0.66% |